Back to Search Start Over

Histopathological growth patterns correlate with the immunoscore in colorectal cancer liver metastasis patients after hepatectomy

Authors :
Qiong Shao
Shaoyan Xi
Binkui Li
De Shen Wang
Yu Hong Li
Zhi Qiang Wang
Fenghua Wang
Xiaojun Wu
Yun Zheng
Rui-Hua Xu
Jie-Ying Liang
Liren Li
Pei-Rong Ding
Yunfei Yuan
Gong Chen
Zhizhong Pan
Source :
Cancer Immunology, Immunotherapy. 69:2623-2634
Publication Year :
2020
Publisher :
Springer Science and Business Media LLC, 2020.

Abstract

Various scoring systems have been proposed to predict the postoperative prognosis of colorectal liver metastasis (CRLM), including the clinical risk score (CRS), the immunoscore and so on. Recently, histopathological growth patterns (HGPs) have been recognized. However, the correlation between HGPs and the immunoscore, and their prognostic values in patients with CRLM after liver resection remain undetermined. In this study, HGPs were retrospectively evaluated in HE-stained slides from 166 CRLM patients. The immunoscore was calculated according to the densities of immunostained CD3 + and CD8 + cells. A risk score combining HGPs, the immunoscore and the CRS was defined and divided patients into the low-, medium- and high-risk group. Our results showed that the densities of CD3 + and CD8 + cells were higher in the desmoplastic HGP (dHGP) group than in the non-dHGP group, and the proportion of high immunoscores was also higher in the dHGP group (51.9% vs. 33.0%, respectively, P = 0.020). Patients with the dHGP had significantly longer relapse-free survival (RFS) and overall survival (OS) than those with the non-HGP. The low-risk group showed significantly higher 2-year RFS and 5-year OS rates than the other two groups (RFS: 76.2%, 43.7% and 33.1%, respectively; P 0.001; OS: 89.7%, 54.4% and 33.3%, respectively; P 0.001). In conclusion, the dHGP correlates with relatively high immunoscores, predicting a favorable prognosis independent of the immunoscore and CRS. A novel risk score combining HGPs, the immunoscore and the CRS may be used for the stratification of CRLM patients' survival.

Details

ISSN :
14320851 and 03407004
Volume :
69
Database :
OpenAIRE
Journal :
Cancer Immunology, Immunotherapy
Accession number :
edsair.doi.dedup.....7ef3008c6006fa40be25b875841fe2d8